Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04297631 · ClinicalTrials.gov registry record · Phase 4

Intraarticular Antibiotic in TKA

A Phase 4 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target

NCT04297631: Completed Phase 4 study, sponsored by Washington University School of Medicine.

NCT04297631 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04297631, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target

Study Summary

The purpose of the study is to determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty and determine the serum concentrations of these antibiotics postoperatively.

Primary Outcome

1\. Determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty.

Interventions

  • DRUG Tobramycin Powder
  • DEVICE Vancomyscin

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-02-14
Est. Completion 2020-11-01
Phase Phase 4

What the finished NCT04297631 record still lists

NCT04297631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Tobramycin Powder is the first listed.

NCT04297631 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04297631 about?

NCT04297631 is a clinical study titled "Intraarticular Antibiotic in TKA". The purpose of the study is to determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty and determine the serum concentrations of these antibiotics postoperatively.

What is the current status of trial NCT04297631?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2020-02-14. Estimated completion is 2020-11-01.

What interventions are being tested in trial NCT04297631?

The interventions under investigation include: Tobramycin Powder (DRUG), Vancomyscin (DEVICE).

Who is sponsoring clinical trial NCT04297631?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04297631's enrollment target sits among peer trials

20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04297631, the US trial registry maintained by the National Library of Medicine. NCT04297631 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.